What to do if your platelets go up and down on Eltrombopag?
Taking Eltrombopag platelets suddenly high and low, it is likely to be caused by improper dosage of medication, you need to go to the hospital in time to do the…
Taking Eltrombopag platelets suddenly high and low, it is likely to be caused by improper dosage of medication, you need to go to the hospital in time to do the…
Eat eltrombopag to stop, need to consult the physician’s judgment of the patient’s condition whether there are indications for stopping the drug, in general, platelets recovered to more than 80,…
Eltrombopag ethanolamine tablets, belonging to the western medicine, Chinese medicine soup and western medicine is not recommended to take at the same time, to avoid interactions between drugs side effects,…
The effects of Eltrombopag are seen 2 to 6 hours after taking it. Eltrombopag is mainly used for the treatment of chronic immune thrombocytopenia in adults, after taking it can…
The correct drug name of Eltrombopag Tablets is Eltrombopag Ethanolamine Tablets, and its price per box is affected by the drug specifications and the purchase area, way and other factors,…
Eltrombopag has a certain therapeutic effect on aplastic anemia, Eltrombopag has the effect of promoting platelet production. Aplastic anemia is a disease in which the blood cells produced by oneself…
Eltrombopag has the efficacy of elevating platelets and can be used to treat primary immune thrombocytopenic purpura and other diseases. 1. Eltrombopag is a thrombopoietin receptor agonist drug, primary immune…
Side effects of Eltrombopag mainly include gastrointestinal disturbances such as nausea, vomiting and dyspepsia, but also thrombocytopenia and bleeding tendencies such as skin petechiae, conjunctival hemorrhages, and menorrhagia. Some patients…
Eltrombopag has a role in the treatment of immune thrombocytopenia, although the drug is not a first-line treatment. The first line of clinical treatment for immune thrombocytopenia is glucocorticoids and…
Eltrombopta is a drug mainly for idiopathic thrombocytopenic purpura, which is not available in China, mainly for second-line treatment of ITP, and has been seen in Hong Kong, as well…